Amphastar制药

AMPH NASDAQ
20.22
-0.42
-2.03%
已收盘, 19:36 06/24 EDT
开盘
20.63
昨收
20.64
最高
20.83
最低
20.17
成交量
18.33万
成交均量(3M)
16.35万
52周最高
25.43
52周最低
15.04
换手率
0.39%
市值
9.52亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Amphastar制药 AMPH股票价格,Amphastar制药股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company focuses primarily on developing, manufacturing, marketing and selling generic and injectable, inhalation and intranasal products. The Company has two segments: finished pharmaceutical products and active pharmaceutical ingredients (API) products. The finished pharmaceutical products segment manufactures, markets and distributes enoxaparin, Cortrosyn, Amphadase, naloxone, lidocaine jelly, as well as various other critical and non-critical care drugs. The API segment manufactures and distributes recombinant human insulin and porcine insulin. The Company also manufactures and sells insulin API. As of December 31, 2016, the Company manufactured and sold 19 products. As of December 31, 2016, the Company developed a portfolio of 15 generic abbreviated new drug applications (ANDAs) three generic biosimilar product candidates and six injectable and inhalation product candidates.
展开 >

最近浏览

名称
价格
涨跌幅